WHO ICTRP trial
A randomized, participant and investigator-blinded, placebo-controlled, single…
JPRN-jRCT2071210115 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2071210115 |
|---|---|
| Public title | A randomized, participant and investigator-blinded, placebo-controlled, single ascending intravenous and single subcutaneous dose study to assess the safety, tolerability and pharmacokinetics of CMK389 in Japanese healthy participants |
| Scientific title | A randomized, participant and investigator-blinded, placebo-controlled, single ascending intravenous and single subcutaneous dose study to assess the safety, tolerability and pharmacokinetics of CMK389 in Japanese healthy participants |
| Primary sponsor | Yamada Hiroyuki |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Japanese healthy participants |
| Interventions | Cohort 1 - Single i.v. infusion of 3 mg/kg CMK389 - Single i.v. infusion of CMK389 placebo arm Cohort 2 - Single i.v. infusion of 10 mg/kg CMK389 - Single i.v. infusion of CMK389 placebo arm Cohort 3 - Single i.v. infusion of 30 mg/kg… |
| Registration date | Jan 21, 2022 |
| Target size | 32 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: